These studies were supported by AstraZeneca Pharmaceuticals LP. HAN has received grant support from AstraZeneca, Janssen, Eli Lilly & Co. and Pfizer; and has served as a consultant for and on the speakers bureau of AstraZeneca, Abbott Laboratories, Janssen, Pfizer and Shire. MB and BP are employees of AstraZeneca.
Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania
Article first published online: 16 OCT 2006
Volume 8, Issue 5p1, pages 467–474, October 2006
How to Cite
Nasrallah, H. A., Brecher, M. and Paulsson, B. (2006), Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disorders, 8: 467–474. doi: 10.1111/j.1399-5618.2006.00350.x
- Issue published online: 16 OCT 2006
- Article first published online: 16 OCT 2006
- Received 13 April 2005, revised and accepted for publication 22 March 2006
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.